Skip to main content

Table 1 Patient, surgical & analgesic demographics

From: Complete opioid transition to sublingual Buprenorphine after abdominal surgery is associated with significant reductions in opioid requirements, but not reduction in hospital length of stay: a retrospective cohort study

 

OOxy (N = 82)

SLBup (N = 64)

p-value

Age (years)

60 (17)

65 (13)

0.05

ASA grade

2

41 (50%)

21 (33%)

0.009

3

37 (45%)

36 (56%)

4

4 (5%)

7 (11%)

Sex (male)

36 (44%)

26 (40%)

0.61

Incisional Pain ordinal scale a (1–3)

1

2

3

22 (27%)

11 (13%)

49 (60%)

36 (56%)

16 (25%)

12 (19%)

0.001

Emergency surgery

28 (34%)

32 (50%)

0.003

Acuity of Surgical Presentation ordinal scaleb (1–5)

1

2

3

4

5

9 (3%)

10 (8%)

41 (49%)

11 (20%)

11 (20%)

2 (1%)

9 (8%)

24 (33%)

14 (26%)

15 (32%)

< 0.0001

Postoperative day transitioned to Oxy or SLBup

1

2

3

4

>  4

29 (35%)

28 (34%)

13 (16%)

8 (10%)

4 (5%)

16 (25%)

20 (31%)

14 (22%)

2 (3%)

12 (19%)

< 0.0001

POD at FWD

1

2

3

4

5

6

7

>  7

6 (8%)

26 (34%)

22 (29%)

14 (18%)

4 (5%)

3 (4%)

1 (1%)

0 (0%)

2 (4%)

4 (8%)

7 (13%)

5 (10%)

12 (23%)

4 (8%)

5 (10%)

13 (24%)

< 0.0001

Duration (Days, POD sips to POD of FWD)

2 (1.2)

3.6 (2.9)

< 0.0001

Length of hospital stay (days)

10 (15)

19 (16)

0.001

Special analgesia techniques (see text)

34 (41%)

25 (39%)

0.8

Laparoscopic vs Open Surgery (Lap %)

49 (60%)

12 (19%)

< 0.0001

  1. Data presented as mean (standard deviation), mean (SD) or number (proportion)
  2. ASA American Society of Anaesthesiologists; FWD full ward diet; OOXY oral oxycodone; POD postoperative day; SLBup sublingual buprenorphine